A team at the Wellcome Trust Sanger Institute has discovered how a promising malarial vaccine target – the protein RH5 – helps parasites to invade human red blood cells. Published today in Nature Communications, the study reveals that a previously mysterious protein on the surface of the parasite called P113 anchors the RH5 protein, and provides a molecular bridge between the parasite and a red blood cell.